Could a 'Poop Transplant' fix a harsh side effect of cancer drugs?
NCT ID NCT04883762
Summary
This small, early-stage study is testing whether a procedure called a fecal microbiota transplant (FMT) can safely help reduce severe diarrhea caused by cancer immunotherapy drugs. The treatment involves transferring stool from a healthy donor into a patient's intestine during a colonoscopy, with the goal of restoring healthy gut bacteria. It is for adults whose severe diarrhea has not improved with standard medications like steroids.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FECAL MICROBIOTA TRANSPLANTATION (FMT) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.